Advertisement

Topics

Search Results for "Pharmaceutical Company Organization Chart"

11:34 EDT 21st October 2017 | BioPortfolio

Matching Channels

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry. For more than two decades, the company has led the industry in developing innovative p...

Connecticut

Connecticut, a state in the north-east corner of the US is a hub for biotechnology companies. There are over 100 high-quality companies with global markets based in Connecticut. In 2004, Connectic...

Visual acuity

Visual acuity (VA) is acuteness or clearness of vision, which is dependent on the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain. Visu...

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

Matching News

The WHO selects Tivanisiran as the international nonproprietary name for SYL1001

(Pharmamar) Sylentis, a Pharmaceutical Company of PharmaMar Group (MCE: PHM), pioneer in the development of new compounds based on genetic silencing technology through RNA interference (RNAi), has ann...

Aoxing Pharmaceutical Company, Inc.: Aoxing Pharmaceutical Announces Delisting and Deregistration of Common Stock

FOSTER CITY, CA / ACCESSWIRE / September 25, 2017 / Aoxing Pharmaceutical Company, Inc. (NYSE American: AXN) today announced that its board of directors has made a determination to remove the Aoxin...

Takeda Pharmaceutical Company Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

Takeda Pharmaceutical Company Limited Strategy, SWOT and Corporate Finance ReportSummaryTakeda Pharmaceutical Company Limited Strategy, SWOT and Corporate Finance Report, is a source of comprehensiv...

Takeda Pharmaceutical Company Limited Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 13062017] Prices from USD $350

Takeda Pharmaceutical Company Limited Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Takeda Pharmaceutical Company Limited Mergers Acquisitions MA, Partne...

Global Survey Reveals "Key Opinion Leader" (KOL) is the Most Commonly Used Term by Pharmaceutical Industry

RALEIGH, N.C., Sept. 19, 2017 /PRNewswire/ -- The Medical Science Liaison Society (MSL Society), the only 501(c)(3) non-profit organization exclusively dedicated to advancing the global medical s...

Chart to Acquire Hudson Products

Enhances Chart’s core platformAdds highly complementary Fans businessStrengthens aftermarket presenceConsistent with Chart’s strategic growth initiativesSignificant cost synergiesEfficient use...

Oasmia Pharmaceutical AB: Issuance of warrants in Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB (publ) (the "Company") resolved, at the Extraordinary General Meeting of the Company on 2 June 2017, to establish two warrant programmes, series 2017:1 and series 2017:2, i...

Pharmaron Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14092017] Prices from USD $250

SummaryPharmaron Inc Pharmaron is a pharmaceutical and biotechnology drug contract research organization that offers research and development services in the areas of chemistry, biology, pharmacology,...

Matching PubMed Articles

Pharmaceutical Marketing for Rare Diseases: Regulating Drug Company Promotion in an Era of Unprecedented Advertisement.

A Standardized Arabic Reading Acuity Chart: The Balsam Alabdulkader-Leat Chart.

The aim of this study was to develop and validate the first standardized Arabic continuous text near-visual-acuity chart, the Balsam Alabdulkader-Leat (BAL) chart.

An attribute control chart for a Weibull distribution under accelerated hybrid censoring.

In this article, an attribute control chart has been proposed using the accelerated hybrid censoring logic for the monitoring of defective items whose life follows a Weibull distribution. The product ...

Conflict of Interest and the CREATE-X Trial in the New England Journal of Medicine.

There is an increasing emphasis on clear disclosure of conflict of interest in medical communities, following repeated scientific frauds in clinical trials. However, incomplete COI statements continue...

Editorial: In Good Company.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement